| Factor Information | |
|---|---|
| Data ID | 502 |
| Factor | left ventricle ejection fraction |
| Description | The left ventricle ejection fraction also showed statistically significant differences. |
| Biomarker | NA |
| Classification | E9 (physiological factor - hemodynamic parameter) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | The left ventricle ejection fraction also showed statistically significant differences. |
| Conclusion | Our patients with CHD and HT are younger and have less CVRF and more cardiac surgeries, which highlights that it is a subgroup with clear clinical differences in its comorbidity and pretransplantation assessment.Therefore, survival at 1-month follow-up is lower than the rest of the series and equalizes after the year of follow-up. This long-term survival reaffirms the possibility of HT in CHD despite the fact that its postoperative period is more difficult. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 462 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | Left UVH/Right UVH/UVH/TA |
| Reference | |
|---|---|
| PMID | 29579880 |
| Year | 2018 |
| Title | Complex Congenital Heart Disease: Is Heart Transplantation an Option? |
| Sample | ||
|---|---|---|
| Population | patients older than 14 years old with CHD and HT | |
| Source | Clinical and surgical variables | |
| Region | Sevilla, Spain | |
| Method | Retrospective analysis | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | Heart transplanted surgery | |
| Group | Heart transplanted patients with CHD(Treatment) | the rest of the transplanted patients(Control) |
| Number | 10 | 428 |
| Age | 25±7 (15-36) years | N/A |
| Gender (Male: Female) | 6:4 | N/A |
| Marker Level | 33.5 (12-67) | 20 (6-70) |
